Jeremy Grantham Regeneron Pharmaceuticals, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$30.8 Billion
Q1 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 83,330 shares of REGN stock, worth $46.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

83,330

Previous 62,979 32.31%

Holding current value

$46.6 Million

Previous $44.9 Million 17.81%

% of portfolio

0.17%

Previous 0.15%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$634.14 - $744.83 $12.9 Million - $15.2 Million	20,351 Added 32.31%	83,330 $52.9 Million
Q4 2024 Feb 13, 2025	BUY	$701.85 - $1046.91 $7.71 Million - $11.5 Million	10,982 Added 21.12%	62,979 $44.9 Million
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $5.39 Million - $6.33 Million	-5,267 Reduced 9.2%	51,997 $54.7 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $526,387 - $638,429	-596 Reduced 1.03%	57,264 $60.2 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $8.34 Million - $9.18 Million	-9,240 Reduced 13.77%	57,860 $55.7 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $7.1 Million - $8.08 Million	9,160 Added 15.81%	67,100 $58.9 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $3.49 Million - $4.25 Million	5,036 Added 9.52%	57,940 $47.7 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $9.97 Million - $11.8 Million	-14,238 Reduced 21.21%	52,904 $38 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $2.72 Million - $3.31 Million	-4,000 Reduced 5.62%	67,142 $55.2 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $12.1 Million - $13.1 Million	17,142 Added 31.74%	71,142 $51.3 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $1.38 Million - $1.74 Million	-2,400 Reduced 4.26%	54,000 $37.2 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $4.66 Million - $6.28 Million	8,500 Added 17.75%	56,400 $33.3 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $297,560 - $349,215	500 Added 1.05%	47,900 $33.5 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $1.03 Million - $1.27 Million	-1,900 Reduced 3.85%	47,400 $29.9 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $459,224 - $544,768	800 Added 1.65%	49,300 $29.8 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $3.26 Million - $3.85 Million	6,900 Added 16.59%	48,500 $27.1 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $6.01 Million - $7.37 Million	13,444 Added 47.75%	41,600 $19.7 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $13.2 Million - $16.8 Million	27,700 Added 6074.56%	28,156 $13.6 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $224,953 - $293,627	456 New	456 $284,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $3.04 Million - $3.53 Million	-11,100 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $3.18 Million - $4.4 Million	10,600 Added 2120.0%	11,100 $3.47 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $186,040 - $219,785	500 New	500 $205,000

Others Institutions Holding REGN

# of Institutions

1,425

Shares Held

85.2M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account